CA Stock MarketDetailed Quotes

PCRX PharmaCorp Rx Inc

Watchlist
  • 0.630
  • +0.010+1.61%
15min DelayMarket Closed Nov 22 16:00 ET
72.84MMarket Cap-24230P/E (TTM)

PharmaCorp Rx Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-77.92%-157.39K
-217.57%-189.3K
-332.22%-519.46K
-5,182.63%-289.96K
-679.91%-81.42K
-351.04%-88.46K
37.80%-59.61K
-120.18K
5.71K
-10.44K
Net income from continuing operations
-759.63%-594.08K
-140.28%-202.47K
9.02%-470.43K
-8,256.90%-216.19K
-589.94%-100.86K
84.53%-69.11K
4.62%-84.26K
---517.09K
---2.59K
--20.59K
Remuneration paid in stock
----
----
--0
--0
----
----
----
--386.28K
--0
--0
Change In working capital
2,227.81%411.82K
-46.59%13.17K
-561.59%-49.03K
-989.66%-73.77K
162.66%19.44K
-147.38%-19.35K
429.04%24.66K
--10.62K
--8.29K
---31.03K
-Change in prepaid assets
--15.79K
---998
----
----
----
----
----
----
----
----
-Change in payables and accrued expense
1,117.88%197K
-42.54%14.17K
400.87%29.72K
-39.95%4.98K
162.66%19.44K
-195.11%-19.35K
429.04%24.66K
---9.88K
--8.29K
---31.03K
-Change in other working capital
----
----
-484.15%-78.75K
----
----
----
----
--20.5K
--0
--0
Cash from discontinued investing activities
Operating cash flow
-77.92%-157.39K
-217.57%-189.3K
-332.22%-519.46K
-5,182.63%-289.96K
-679.91%-81.42K
-351.04%-88.46K
37.80%-59.61K
---120.18K
--5.71K
---10.44K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
252,964.26%19.84M
0
-98.51%27.84K
0
0
-99.58%7.84K
20K
1.87M
0
0
Net common stock issuance
251,076.81%19.69M
--0
-98.61%27.84K
--0
--0
-99.61%7.84K
--20K
--2M
--0
--0
Net other financing activities
----
----
----
----
----
----
----
---126.46K
--0
--0
Cash from discontinued financing activities
Financing cash flow
252,964.26%19.84M
--0
-98.51%27.84K
--0
--0
-99.58%7.84K
--20K
--1.87M
--0
--0
Net cash flow
Beginning cash position
-23.81%2.05M
-17.99%2.24M
178.91%2.73M
-7.18%2.53M
-4.56%2.61M
204.66%2.69M
178.91%2.73M
--980.03K
--2.73M
--2.74M
Current changes in cash
24,604.68%19.76M
-377.92%-189.3K
-128.04%-491.62K
-5,182.63%-289.96K
-679.91%-81.42K
-104.35%-80.62K
58.67%-39.61K
--1.75M
--5.71K
---10.44K
End cash Position
734.57%21.81M
-23.81%2.05M
-17.99%2.24M
-17.99%2.24M
-7.18%2.53M
-4.56%2.61M
204.66%2.69M
--2.73M
--2.73M
--2.73M
Free cash from
-85.71%-164.28K
-217.57%-189.3K
-332.22%-519.46K
-5,182.63%-289.96K
-679.91%-81.42K
-351.04%-88.46K
37.80%-59.61K
---120.18K
--5.71K
---10.44K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -77.92%-157.39K-217.57%-189.3K-332.22%-519.46K-5,182.63%-289.96K-679.91%-81.42K-351.04%-88.46K37.80%-59.61K-120.18K5.71K-10.44K
Net income from continuing operations -759.63%-594.08K-140.28%-202.47K9.02%-470.43K-8,256.90%-216.19K-589.94%-100.86K84.53%-69.11K4.62%-84.26K---517.09K---2.59K--20.59K
Remuneration paid in stock ----------0--0--------------386.28K--0--0
Change In working capital 2,227.81%411.82K-46.59%13.17K-561.59%-49.03K-989.66%-73.77K162.66%19.44K-147.38%-19.35K429.04%24.66K--10.62K--8.29K---31.03K
-Change in prepaid assets --15.79K---998--------------------------------
-Change in payables and accrued expense 1,117.88%197K-42.54%14.17K400.87%29.72K-39.95%4.98K162.66%19.44K-195.11%-19.35K429.04%24.66K---9.88K--8.29K---31.03K
-Change in other working capital ---------484.15%-78.75K------------------20.5K--0--0
Cash from discontinued investing activities
Operating cash flow -77.92%-157.39K-217.57%-189.3K-332.22%-519.46K-5,182.63%-289.96K-679.91%-81.42K-351.04%-88.46K37.80%-59.61K---120.18K--5.71K---10.44K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 252,964.26%19.84M0-98.51%27.84K00-99.58%7.84K20K1.87M00
Net common stock issuance 251,076.81%19.69M--0-98.61%27.84K--0--0-99.61%7.84K--20K--2M--0--0
Net other financing activities -------------------------------126.46K--0--0
Cash from discontinued financing activities
Financing cash flow 252,964.26%19.84M--0-98.51%27.84K--0--0-99.58%7.84K--20K--1.87M--0--0
Net cash flow
Beginning cash position -23.81%2.05M-17.99%2.24M178.91%2.73M-7.18%2.53M-4.56%2.61M204.66%2.69M178.91%2.73M--980.03K--2.73M--2.74M
Current changes in cash 24,604.68%19.76M-377.92%-189.3K-128.04%-491.62K-5,182.63%-289.96K-679.91%-81.42K-104.35%-80.62K58.67%-39.61K--1.75M--5.71K---10.44K
End cash Position 734.57%21.81M-23.81%2.05M-17.99%2.24M-17.99%2.24M-7.18%2.53M-4.56%2.61M204.66%2.69M--2.73M--2.73M--2.73M
Free cash from -85.71%-164.28K-217.57%-189.3K-332.22%-519.46K-5,182.63%-289.96K-679.91%-81.42K-351.04%-88.46K37.80%-59.61K---120.18K--5.71K---10.44K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data